Man Uses Snake Venom on Himself to Develop Universal Antivenom

Added:

Origins & Drive
First Encounters
Self-Experimentation
Proving Immunity
Media & Recognition
Milestones & Setbacks
The Human Antivenom
Future Mission

Origins & Drive

2:04
Playing Section
  • 1

    Hosts discuss community and introduce Tim's extreme background.

  • 2

    Tim describes his childhood interest in snakes in Wisconsin.

Understanding of the human immune system, specifically active immunity, antibodies, and how the body responds to foreign pathogens (antigens).
Basic biochemistry of snake venom, including the differences between neurotoxins, hemotoxins, and cytotoxins and their physiological effects.
The traditional methodology of antivenom production, which typically involves immunizing host animals (like horses or sheep) and harvesting their antibodies.
The concept of toxicity threshold (LD50) and the inherent physiological dangers of direct exposure to lethal venoms.
Investigation into modern biotechnological alternatives for universal antivenom, such as recombinant monoclonal antibodies and synthetic biology.
The physiological and pathological long-term effects of chronic venom exposure on human organs (e.g., liver and kidney damage, autoimmune reactions).
The ethical, legal, and regulatory frameworks governing human self-experimentation and clinical trials in modern medicine.
Analysis of snakebite envenomation as a neglected tropical disease and the global socio-economic challenges of antivenom distribution.
843 views15likes1:07:43@apexcommunicationsnetwork8090Original Release: 2020-07-04

Tim Friede, a Wisconsin truck mechanic, has endured approximately 200 self-inflicted snake bites and 700+ venom injections since 2000 to develop immunity against snake venom, collaborating with immunologist Dr. Jacob Glanville and Distributed Bio to engineer a universal human-based antivenom that could save the 125,000 people who die annually from snakebites worldwide.